INTERFERON BETA-1B

被引：41

作者：

GOODKIN, DE

机构：

[1] UCSF/Mount Zion Multiple Sclerosis Center, San Francisco, CA 94115-1610

来源：

LANCET | 1994年 / 344卷 / 8929期

关键词：

D O I：

10.1016/S0140-6736(94)91713-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1057 / 1060

页数：4

共 28 条

[21]

RUDICK RA, 1992, TREATMENT MULTIPLE S

[22] AUTOIMMUNE-DISEASE [J].

STEINMAN, L .

SCIENTIFIC AMERICAN, 1993, 269 (03) :106-+

[23] INTERFERON - IMMUNOBIOLOGY AND CLINICAL-SIGNIFICANCE [J].

STIEHM, ER ;

KRONENBERG, LH ;

ROSENBLATT, HM ;

BRYSON, Y ;

MERIGAN, TC .

ANNALS OF INTERNAL MEDICINE, 1982, 96 (01) :80-93

[24]

The IFNB Multiple Sclerosis Study Group, 1993, NEUROLOGY, V43, P655

[25] MAJOR DIFFERENCES IN THE DYNAMICS OF PRIMARY AND SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS [J].

THOMPSON, AJ ;

KERMODE, AG ;

WICKS, D ;

MACMANUS, DG ;

KENDALL, BE ;

KINGSLEY, DPE ;

MCDONALD, WI .

ANNALS OF NEUROLOGY, 1991, 29 (01) :53-62

[26]

THOMPSON MR, 1985, J BIOL CHEM, V260, P563

[27] OVERVIEW OF AZATHIOPRINE TREATMENT IN MULTIPLE-SCLEROSIS [J].

YUDKIN, PL ;

ELLISON, GW ;

GHEZZI, A ;

GOODKIN, DE ;

HUGHES, RAC ;

MCPHERSON, K ;

MERTIN, J ;

MILANESE, C .

LANCET, 1991, 338 (8774) :1051-1055

[28]

1990, VITAL HLTH STATIS 10, V176

← 1 2 3 →